These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 27013610)

  • 1. Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis.
    Furuhashi M; Fuseya T; Murata M; Hoshina K; Ishimura S; Mita T; Watanabe Y; Omori A; Matsumoto M; Sugaya T; Oikawa T; Nishida J; Kokubu N; Tanaka M; Moniwa N; Yoshida H; Sawada N; Shimamoto K; Miura T
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):825-34. PubMed ID: 27013610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitatory effects of fetuin-A on atherosclerosis.
    Naito C; Hashimoto M; Watanabe K; Shirai R; Takahashi Y; Kojima M; Watanabe R; Sato K; Iso Y; Matsuyama TA; Suzuki H; Ishibashi-Ueda H; Watanabe T
    Atherosclerosis; 2016 Mar; 246():344-51. PubMed ID: 26828753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury.
    Fuseya T; Furuhashi M; Matsumoto M; Watanabe Y; Hoshina K; Mita T; Ishimura S; Tanaka M; Miura T
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28903937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between perivascular adipose tissue surrounding the heart and the internal mammary artery: possible role for the leptin-inflammation-fibrosis-hypoxia axis.
    Drosos I; Chalikias G; Pavlaki M; Kareli D; Epitropou G; Bougioukas G; Mikroulis D; Konstantinou F; Giatromanolaki A; Ritis K; Münzel T; Tziakas D; Konstantinides S; Schäfer K
    Clin Res Cardiol; 2016 Nov; 105(11):887-900. PubMed ID: 27337945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between visceral/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome.
    Gormez S; Erdim R; Akan G; Caynak B; Duran C; Gunay D; Sozer V; Atalar F
    Cardiovasc Pathol; 2020; 46():107192. PubMed ID: 31927390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin/T-cadherin and apelin/APJ expression in human arteries and periadventitial fat: implication of local adipokine signaling in atherosclerosis?
    Kostopoulos CG; Spiroglou SG; Varakis JN; Apostolakis E; Papadaki HH
    Cardiovasc Pathol; 2014; 23(3):131-8. PubMed ID: 24675084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
    Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-expression variant of fatty acid-binding protein 4 favors reduced manifestations of atherosclerotic disease and increased plaque stability.
    Saksi J; Ijäs P; Mäyränpää MI; Nuotio K; Isoviita PM; Tuimala J; Lehtonen-Smeds E; Kaste M; Jula A; Sinisalo J; Nieminen MS; Lokki ML; Perola M; Havulinna AS; Salomaa V; Kettunen J; Jauhiainen M; Kovanen PT; Lindsberg PJ
    Circ Cardiovasc Genet; 2014 Oct; 7(5):588-98. PubMed ID: 25122052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference-based silencing reveals the regulatory role of fatty acid-binding protein 4 in the production of IL-6 and vascular endothelial growth factor in 3T3-L1 adipocytes.
    Kajimoto K; Takayanagi S; Sasaki S; Akita H; Harashima H
    Endocrinology; 2012 Nov; 153(11):5629-36. PubMed ID: 23008513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counteractive effects of omentin-1 against atherogenesis†.
    Watanabe K; Watanabe R; Konii H; Shirai R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    Cardiovasc Res; 2016 May; 110(1):118-28. PubMed ID: 26790473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages.
    Hu W; Zhou X; Jiang M; Duan Y; Chen Y; Li X; Yin Z; He GW; Yao Z; Zhu Y; Hajjar DP; Han J
    Atherosclerosis; 2012 Jun; 222(2):434-43. PubMed ID: 22503826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events.
    Peeters W; de Kleijn DP; Vink A; van de Weg S; Schoneveld AH; Sze SK; van der Spek PJ; de Vries JP; Moll FL; Pasterkamp G
    Eur Heart J; 2011 Jul; 32(14):1758-68. PubMed ID: 21059735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells.
    Chadjichristos CE; Morel S; Derouette JP; Sutter E; Roth I; Brisset AC; Bochaton-Piallat ML; Kwak BR
    Circ Res; 2008 Mar; 102(6):653-60. PubMed ID: 18239136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoplasmic reticulum stress in perivascular adipose tissue promotes destabilization of atherosclerotic plaque by regulating GM-CSF paracrine.
    Ying R; Li SW; Chen JY; Zhang HF; Yang Y; Gu ZJ; Chen YX; Wang JF
    J Transl Med; 2018 Apr; 16(1):105. PubMed ID: 29669585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating FABP4 is a prognostic biomarker in patients with acute coronary syndrome but not in asymptomatic individuals.
    Reiser H; Klingenberg R; Hof D; Cooksley-Decasper S; Fuchs N; Akhmedov A; Zoller S; Marques-Vidal P; Marti Soler H; Heg D; Landmesser U; Rodondi N; Mach F; Windecker S; Vollenweider P; Matter CM; Lüscher TF; von Eckardstein A; Gawinecka J
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1872-9. PubMed ID: 26069234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between epicardial adipose tissue volume measured using coronary computed tomography angiography and atherosclerotic plaque characteristics in patients with severe coronary artery stenosis.
    Dong DD; Wang K; Wang D; Zhang T; Tu YF; Shen BZ
    J Int Med Res; 2013 Oct; 41(5):1520-31. PubMed ID: 24045168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between plaque vulnerability of aorta and coronary artery: an evaluation of plaque activity by direct visualization with angioscopy.
    Aono J; Ikeda S; Katsumata Y; Higashi H; Ohshima K; Ishibashi K; Matsuoka H; Watanabe K; Hamada M
    Int J Cardiovasc Imaging; 2015 Aug; 31(6):1107-14. PubMed ID: 25916323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of NLRP3 in subcutaneous adipose tissue is associated with coronary atherosclerosis.
    Bando S; Fukuda D; Soeki T; Nishimoto S; Uematsu E; Matsuura T; Ise T; Tobiume T; Yamaguchi K; Yagi S; Iwase T; Yamada H; Wakatsuki T; Shimabukuro M; Sata M
    Atherosclerosis; 2015 Oct; 242(2):407-14. PubMed ID: 26282945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
    Suhre K; Römisch-Margl W; de Angelis MH; Adamski J; Luippold G; Augustin R
    J Biomol Screen; 2011 Jun; 16(5):467-75. PubMed ID: 21543640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.